218 related articles for article (PubMed ID: 28756598)
1. Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species.
Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Spiliopoulou I; Tanaseskou L; Karpetas G; Marangos M; Anastassiou ED; Christofidou M
Infection; 2017 Oct; 45(5):651-657. PubMed ID: 28756598
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit.
Pratikaki M; Platsouka E; Sotiropoulou C; Douka E; Paramythiotou E; Kaltsas P; Kotanidou A; Paniara O; Roussos C; Routsi C
Mycoses; 2011 Mar; 54(2):154-61. PubMed ID: 19793354
[TBL] [Abstract][Full Text] [Related]
4. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
[TBL] [Abstract][Full Text] [Related]
7. Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species.
Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Manolopoulou P; Spiliopoulou I; Vrettos T; Dodou V; Filos KS; Anastassiou ED; Marangos M; Christofidou M
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):227-32. PubMed ID: 25175179
[TBL] [Abstract][Full Text] [Related]
8. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.
Keighley C; Chen SC; Marriott D; Pope A; Chapman B; Kennedy K; Bak N; Underwood N; Wilson HL; McDonald K; Darvall J; Halliday C; Kidd S; Nguyen Q; Hajkowicz K; Sorrell TC; Van Hal S; Slavin MA
BMC Infect Dis; 2019 May; 19(1):445. PubMed ID: 31113382
[TBL] [Abstract][Full Text] [Related]
9. ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
Baldesi O; Bailly S; Ruckly S; Lepape A; L'Heriteau F; Aupee M; Boussat S; Bervas C; Machut A; Berger-Carbonne A; Savey A; Timsit JF;
J Infect; 2017 Jul; 75(1):59-67. PubMed ID: 28366686
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.
Yeşilkaya A; Azap Ö; Aydın M; Akçil Ok M
Mycoses; 2017 Jul; 60(7):433-439. PubMed ID: 28338249
[TBL] [Abstract][Full Text] [Related]
12. A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.
Zeng Z; Ding Y; Tian G; Yang K; Deng J; Li G; Liu J
Antimicrob Resist Infect Control; 2020 Aug; 9(1):133. PubMed ID: 32799915
[TBL] [Abstract][Full Text] [Related]
13. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.
Papadimitriou-Olivgeris M; Fligou F; Bartzavali C; Zotou A; Spyropoulou A; Koutsileou K; Vamvakopoulou S; Sioulas N; Karamouzos V; Anastassiou ED; Spiliopoulou I; Christofidou M; Marangos M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1125-1131. PubMed ID: 28102514
[TBL] [Abstract][Full Text] [Related]
14. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
Swoboda SM; Merz WG; Lipsetta PA
Surg Infect (Larchmt); 2003; 4(4):345-54. PubMed ID: 15012861
[TBL] [Abstract][Full Text] [Related]
15. Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults.
Troughton JA; Browne G; McAuley DF; Walker MJ; Patterson CC; McMullan R
J Infect; 2010 Nov; 61(5):403-9. PubMed ID: 20849877
[TBL] [Abstract][Full Text] [Related]
16. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
17. Our 2014 approach to candidaemia.
Koehler P; Tacke D; Cornely OA
Mycoses; 2014 Oct; 57(10):581-3. PubMed ID: 24863378
[TBL] [Abstract][Full Text] [Related]
18. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
[TBL] [Abstract][Full Text] [Related]
19. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
20. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
